Celltech Chiroscience Strikes Chirocaine Deal With Abbott/Purdue
Executive Summary
The local anesthetic Chirocaine (levobupivacaine) will be the first commercialized drug from the merged U.K. biopharmaceutical entity Celltech Chiroscience.
You may also be interested in...
Celltech Chiroscience Acquisition Of Medeva Provides Marketing Muscle
Medeva will bring a sales force of 400 reps, including 180 reps in the U.S., to the proposed merger with Celltech Chiroscience.
Celltech Chiroscience Acquisition Of Medeva Provides Marketing Muscle
Medeva will bring a sales force of 400 reps, including 180 reps in the U.S., to the proposed merger with Celltech Chiroscience.
Pharmagene Financing To Grow Preclinical Human Tissue Research Service
The U.K. biotech company Pharmagene will use a private placement of $13.8 mil. (L8.6 mil.) to expand the company's Phase Zero target validation technologies and database products.